Galena Biopharma, Inc. (SLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

NASA's SLS rocket spent over a decade in development, and each of its launches of the Orion crew capsule is expected to cost about $4.1 billion.

The SLS was sold to the public as a rocket that would be developed on time and on budget because it was ... it's the political price the agency had to pay to bring Congress on board with a real ...

At the time I left NASA in 2013, I said "I think SLS is going to slip a year or two." NASA came back and said, "she's wrong, it's not slipping." And the head of SLS for Boeing said "it's ahead of ...

The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31, 2023.

TSE SLS opened at C$4.86 on Wednesday. The company has a market cap of C$557.51 million, a PE ratio of -8.47 and a beta of 1.90. The company has a debt-to-equity ratio of 712.38, a quick ratio of ...